Action Clearmind Medicine - CMND

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

1,06

Prix Achat

1,06

Prix Vente

1,13

Volume échangé

51 234

1,06 Fourchette du Jour 1,11

0,9512 Plage de 52 semaines 2,30

Clôture Veille

1,11

Ouverture

1,11

Dernière Transaction

1.1299

Dernière heure de transaction

Volume moyen (3 m)

1 134 968

Volume financier

US$ 55 632

VWAP

1,0858

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a...

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0...

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.17	-13.8211382114	1.23	1.28	1.06	38367	1.14980009	CS
4	-0.35	-24.8226950355	1.41	1.45	1.06	49882	1.29557893	CS
12	-0.42	-28.3783783784	1.48	2.18	1.06	1134968	1.67881285	CS
26	-0.21	-16.5354330709	1.27	2.18	1.06	633956	1.63462775	CS
52	-0.46	-30.2631578947	1.52	2.3	0.9512	766685	1.51074922	CS
156	-161.54	-99.3480934809	162.6	183	0.9205	1082498	9.24432171	CS
260	-161.54	-99.3480934809	162.6	183	0.9205	1082498	9.24432171	CS

CMND - Frequently Asked Questions (FAQ)

What is the current Clearmind Medicine share price?

The current share price of Clearmind Medicine is US$ 1,06

What is the 1 year trading range for Clearmind Medicine share price?

Clearmind Medicine has traded in the range of US$ 0,9512 to US$ 2,30 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ABLVAble View Global Inc	US$ 1,73 (137,18%)	5,05M
SUNESUNation Energy Inc	US$ 0,402999 (127,55%)	481,25M
BTOGBit Origin Ltd	US$ 0,6117 (118,46%)	621,45M
DWTXDogwood Therapeutics Inc	US$ 6,63 (49,66%)	25,88M
KZIAKazia Therapeutics Ltd	US$ 1,1899 (40,80%)	4,5M
ALBTAvalon GloboCare Corporation	US$ 6,96 (-36,15%)	575,55k
SCNXScienture Holdings Inc	US$ 1,55 (-35,68%)	1,59M
ACXPAcurx Pharmaceuticals Inc	US$ 0,4572 (-29,88%)	1,18M
RETOReTo Eco Solutions Inc	US$ 5,42 (-27,73%)	107,97k
OCTOEightco Holdings Inc	US$ 1,08 (-27,03%)	336,54k
BTOGBit Origin Ltd	US$ 0,6117 (118,46%)	621,45M
SUNESUNation Energy Inc	US$ 0,402999 (127,55%)	481,25M
NVDANVIDIA Corporation	US$ 112,69 (1,92%)	341,63M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10,675 (-0,70%)	142,89M
ICONIcon Energy Corporation	US$ 0,169898 (17,17%)	140,55M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Clearmind Medicine Inc (CMND)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

CMND Dernières nouvelles

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

CMND - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Clearmind Medicine Inc (CMND) Cours

Clearmind Medicine Inc (CMND)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

CMND Dernières nouvelles

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

CMND - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités